A Growing Problem

Skin Cancer a growing problem among the aging population

Skin cancer accounts for more than 40% of all malignancies in the United States. Moreover, greater than 50% of skin cancers occur in those over 60 years of age. This population also has a high incidence of risk associated with surgical procedures due to various disorders like diabetes and cardiac diseases that can slow the healing process.

The traditional treatment path for non-melanoma skin cancer has been Mohs surgery. This surgery involves a series of excisions of cancerous tissue and surrounding healthy tissue until the cancer can no longer be detected. This procedure can lead to substantial cosmetic surgery requirements and a drawn-out healing process which can result in infection.

Therapy Modalities Comparison

XStrahl-100™  VS

Mohs LINAC HDR PDT Topicals Mohs Surgery Y Y N 1-3 hours Surgery Incision Invasive 0-2 cm N Y Y Recon. Surgery High $1,270 1 30 to 50 Surgery/Staff/Lab N Y Dermatologist Only 98% 2% LINAC EBRT Y Y Y 30 Min High Dose Radiation Electrons Invasive Beam 1-50 cm 20-35 Fractions N N N Very High $4,700 2 15 to 25 Concrete Vault N N RadOnc Only 88% 12% Brachytherapy Y Y N 30 Min to 1 hour High Energy Isotopes Gamma Particles Superficial/Interstitial 0-1 cm 6-15 Fractions Y When Interstitial N High $5,250 2 5 to 10 Heavy Shielding Y Y RadOnc Only 95% 5% Photodynamic Y Y N 30 Min High Energy Light Photons Superficial 4 mm N Y N N Low N/A 2 N/A Photosensitive Drugs Y Y Dermatologist 70% 30% Topicals Y Y N 10 Min Chemotherapy Bio-Chemical Superficial 0 cm 40-200 Fractions N N N Low N/A 6 N/A None Y Y Dermatologist 65% 35%

. Parameters SRT Basal Cell Y Squamous Cell Y  Melanoma N  Procedure Time 90 sec  Treatment Type Low Dose X-ray Particle Type/Delivery Mode Photons  Modality Therapy Mode Superficial Penetration Rate 0-1 cm  Fractionated Treatment 5-22 Fractions  Pain Involved? N  Anesthesia Required? N  Post-Procedural Treatment N  Practice Setup/Cost of Entry Low  Avg. Reimbursement / Patient $1,350  Max. Patient Throughput / Hr 12  Break-even Patients / Month 3 to 4  Special Provisions Minimal Shielding  Mobile? Y Ongoing Consumable Costs? N Who Can Administer Dermatologist/RadOnc Cure Rates 98% Recurrence Rates 2%

 Source:  ©2011

• < Prev
• Next >